✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Groups 1, 2, and 3 have ABG level of
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Introduction: The admission blood glucose (ABG) level is associated with increased mortality in non-diabetics patients with Coronavirus disease-2019 (COVID-19) in short-term follow-up studies.
📊
Key Findings & Data:However, post-discharge mortality has also increased in COVID-19.
💡
Conclusion & Impact:Groups 1, 2, and 3 have ABG level of
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Abstract
Introduction: The admission blood glucose (ABG) level is associated with increased mortality in non-diabetics patients with Coronavirus disease-2019 (COVID-19) in short-term follow-up studies. However, post-discharge mortality has also increased in COVID-19. Thus, this study aimed to examine the relationship between ABG and 90-day mortality including the post-discharge period. Methods: Non-diabetic patients who are hospitalized due to COVID-19 in 2020 were evaluated. Patients were divided into groups according to the ABG level. Groups 1, 2, and 3 have ABG level of
🔖
Cite This Article
KARAKILIÇ, E., SAYGILI, E. S. (2022). The Relationship Between the Admission Blood Glucose Level and 90-Day Mortality in Non-Diabetic Patients with Coronavirus Disease-2019. İstanbul Medical Journal, Cilt: 23 - Sayı: 1, 39–44. https://ajindex.com/articles/551754